Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
- PMID: 21658092
- PMCID: PMC3244636
- DOI: 10.1111/j.1365-2125.2011.04037.x
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
Comment on
-
Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.Br J Clin Pharmacol. 2011 Dec;72(6):898-904. doi: 10.1111/j.1365-2125.2011.04009.x. Br J Clin Pharmacol. 2011. PMID: 21557759 Free PMC article.
References
-
- Chavant F, Favrelière S, Lafay-Chebassier C, Plazanet C, Pérault-Pochat M. Memory disorders associated with drugs consumption: updating through a case/non-case study in the French PharmacoVigilance Database. Br J Clin Pharmacol. 2011 doi: 10.1111/j.1365-2125.2011.04009.x (Epub ahead of print) - DOI - PMC - PubMed
-
- Robert E, Rosa F. Valproate and birth defects. Lancet. 1983;322:1142. doi: 10.1016/S0140-6736(83)90656-6. - DOI - PubMed
-
- Stricker BH, Tijssen JG. Serum sickness-like reactions to cefaclor. J Clin Epidemiol. 1992;45:1177–84. - PubMed
-
- Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13:519–23. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical